Bo Chen

机构：First Affiliated Hospital of Shihezi University Medical College · ORCID：0000-0001-8118-2405

发表论文 85 篇 · 总被引 779 次 · h-index 17

代表论文

• Endoplasmic reticulum stress inhibits AR expression via the PERK/eIF2α/ATF4 pathway in luminal androgen receptor triple-negative breast cancer and prostate cancer (2022 · npj Breast Cancer · 被引 29)
• Salivary gland protective and antiinflammatory effects of genistein in Sjögren’s syndrome by inhibiting Xist/ACSL4-mediated ferroptosis following binding to estrogen receptor-alpha (2024 · Cellular & Molecular Biology Letters · 被引 26)
• Comprehensive analysis and validation reveal potential MYCN regulatory biomarkers associated with neuroblastoma prognosis (2022 · Journal of Biomolecular Structure and Dynamics · 被引 13)
• Rare Variants in Novel Candidate Genes Associated With Nonsyndromic Patent Ductus Arteriosus Identified With Whole-Exome Sequencing (2022 · Frontiers in Genetics · 被引 7)
• SNORA47 affects stemness and chemotherapy sensitivity via EBF3/RPL11/c-Myc axis in luminal A breast cancer (2025 · Molecular Medicine · 被引 6)
• SESN1 functions as a new tumor suppressor gene via Toll‐like receptor signaling pathway in neuroblastoma (2024 · CNS Neuroscience & Therapeutics · 被引 5)